Salivary IL-6 Concentration Is Associated with Frailty Syndrome in Older Individuals
Open Access
- 5 January 2022
- journal article
- research article
- Published by MDPI AG in Diagnostics
- Vol. 12 (1) , 117
Abstract
Background: One of the physiological changes that is most closely associated with frailty is the increase in pro-inflammatory cytokines, and IL-6 in particular. Most studies have demonstrated this association using blood samples. We analyzed the relationship between frailty syndrome, individual frailty criteria, and IL-6 levels obtained by saliva tests. Methods: A cross-sectional pilot study was performed among women institutionalized in nursing homes. Frailty was defined as having three or more of the following components: low lean mass, weakness, self-reported exhaustion, low activity level, and slow walking speed; prefrailty was defined as having one or two of those components. Results: There was a significant and positive correlation between the frailty score and salivary IL-6 concentration. Regarding the associations between IL-6 and individual dichotomized frailty criteria, there were significant differences in salivary IL-6 concentration in two frailty criteria: weight loss (p = 0.002) and low physical activity (p = 0.007). Receiver operating characteristic curve analysis showed that IL-6 concentration significantly (p < 0.05) (although moderately) discriminated patients that progressed in the frailty syndrome (the area under the curve value was 0.697 with 95% CI 0.566–0.827). Conclusions: Salivary IL-6 concentration can be used as potential biomarker of frailty syndrome and as a tool to monitor the effects of interventions in frail individuals.Keywords
This publication has 78 references indexed in Scilit:
- Is There an Interaction Between Polycystic Ovary Syndrome and Gingival Inflammation?Journal of Periodontology, 2012
- Pathways to Interleukin-6 in Healthy Males and Serious Leisure Male Athletes: Physical Activity, Body Composition and AgePLOS ONE, 2012
- IL-6-independent association of elevated serum neopterin levels with prevalent frailty in community-dwelling older adultsAge and Ageing, 2011
- Higher Inflammatory Marker Levels in Older Persons: Associations With 5-Year Change in Muscle Mass and Muscle StrengthThe Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2009
- Upregulated monocytic expression of CXC chemokine ligand 10 (CXCL-10) and its relationship with serum interleukin-6 levels in the syndrome of frailtyCytokine, 2009
- Evaluation of saliva collection devices for the analysis of steroids, peptides and therapeutic drugsJournal of Pharmaceutical and Biomedical Analysis, 2008
- Interleukin-6 does/does not have a beneficial role in insulin sensitivity and glucose homeostasisJournal of Applied Physiology, 2007
- The Metabolic Syndrome, Inflammation, and Risk of Cognitive DeclineJAMA, 2004
- Biomarkers and surrogate endpoints: Preferred definitions and conceptual frameworkClinical Pharmacology & Therapeutics, 2001
- The CES-D ScaleApplied Psychological Measurement, 1977